Company profile: Clean Cells
1.1 - Company Overview
Company description
- Provider of biosafety and quality control testing for biopharmaceuticals, including vaccines, monoclonal antibodies, and cell and gene therapies; GMP manufacturing of cell and virus banks and Master/Working Cell Banks; secure GMP and non-GMP storage; development of cytotoxicity potency assays; purity and identity testing; and production of experimental drugs such as cell therapy products and therapeutic phages.
Products and services
- Manufacturing: Produces GMP-compliant Master and Working Cell Banks for vaccines, gene therapy products, and recombinant proteins, including monoclonal antibodies
- Quality Control Testing: Delivers industrial-grade biosafety testing for vaccines, monoclonal antibodies, and cell and gene therapies using cell culture, molecular, and immune-enzymatic methods to assess viral and biological safety
- Storage: Supplies GMP-grade, secure, long-term storage solutions for cell banks in both GMP and non-GMP environments
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Clean Cells
AMSBIO
HQ: United Kingdom
Website
- Description: Provider of life science technology products and services for R&D in medical, nutrition, cosmetics, and energy, including monoclonal, polyclonal, and secondary antibodies; GMP compliance support; FDA-aligned tissue arrays for immunohistochemistry; protein expression; transduction-ready lentivirus, adenovirus, and AAV; and peptide and antibody production services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AMSBIO company profile →
Tentarix
HQ: United States
Website
- Description: Provider of protein therapeutics and discovery platforms leveraging synthetic biology, including the Tentacles platform for multifunctional, conditionally active antibody-based biologics that activate immune cells and modulate disease while minimizing safety concerns; CellSurf to understand cell surface proteomes; HuTARG mammalian display to discover fully human binders; and FunctionSeq high-throughput screening of multifunctional biologics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tentarix company profile →
Labcyte
HQ: United States
Website
- Description: Provider of Echo Acoustic Liquid Handling systems and laboratory instrumentation for life sciences applications, using focused acoustic energy to eject nanoliter-scale droplets from one plate to another with high accuracy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Labcyte company profile →
Ahura Scientific
HQ: United States
Website
- Description: Provider of rugged, ultra-compact, field-enabled optical systems for the immediate identification and authentication of liquid and solid chemical substances, serving homeland security, life sciences, industrial, and medical markets; products include handheld XRF and LIBS analyzers, portable narcotics and chemical identifiers, manufactured in the USA in an ISO 9001-certified facility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ahura Scientific company profile →
Zedira
HQ: Germany
Website
- Description: Provider of transglutaminase-focused biotech solutions, including specialty reagents for R&D and diagnostics; small-molecule drug candidates such as ZED1227 for celiac disease; fee-for-service transglutaminase activity measurement; recombinant microbial transglutaminase (Andracon) for ADC production; diagnostic antigens (TG2, TG3, TG6, DGPs); and an Anti-TG6 ELISA kit.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Zedira company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Clean Cells
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Clean Cells
2.2 - Growth funds investing in similar companies to Clean Cells
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Clean Cells
4.2 - Public trading comparable groups for Clean Cells
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →